Mitchell McLeod Pugh & Williams’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-12,000
Closed -$28.7K 266
2023
Q3
$28.7K Hold
12,000
0.01% 251
2023
Q2
$27.7K Hold
12,000
0.01% 251
2023
Q1
$30.6K Hold
12,000
0.01% 252
2022
Q4
$30.1K Buy
+12,000
New +$33.5K 0.01% 245

Other funds holding SLGC

Mitchell McLeod Pugh & Williams's SLGC Position: Q4 2023 in Review

Mitchell McLeod Pugh & Williams sold out of SomaLogic, Inc. Class A Common Stock (SLGC) in Q4 2023, closing a stake of 12,000 shares — an estimated $28.7K sold.

Mitchell McLeod Pugh & Williams first reported a position in SLGC in Q4 2022 and held it in 4 quarters. The position peaked at $30.6K in Q1 2023. 119 funds tracked by Wall St. Rank hold SLGC as of Q4 2023.

  • Mitchell McLeod Pugh & Williams reported no remaining SomaLogic, Inc. Class A Common Stock position as of Q4 2023 after selling out during the quarter.
  • Mitchell McLeod Pugh & Williams sold 12,000 SomaLogic, Inc. Class A Common Stock shares in Q4 2023, an estimated $28.7K.
  • Mitchell McLeod Pugh & Williams first reported a position in SomaLogic, Inc. Class A Common Stock in Q4 2022 and held it in 4 quarters.
  • Mitchell McLeod Pugh & Williams's SomaLogic, Inc. Class A Common Stock position peaked at $30.6K in Q1 2023.
  • 119 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q4 2023.

Based on Mitchell McLeod Pugh & Williams's 13F filing for Q4 2023, filed 5 Feb 2024.